Get startedLog in
    Picture of Odi Pharma AB (publ) logo

    ODI — Odi Pharma AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    All News

    Brief: ODI Pharma Says Group's Net Sales For Q2 Amounted To Sek 458,620

    Picture of Odi Pharma AB (publ) logoOdi Pharma AB (publ)
    24/02/2022 18:52
    Feb 24 (Reuters) - Odi Pharma AB (publ)  ODI.TE :
    * Q2 GROUP'S NET SALES AMOUNTED TO SEK 458,620
    * Q2 RESULT PER SHARE AMOUNTED TO SEK -0.13 (-0.05)
    * GROUP'S LOSS AFTER FINANCIAL ITEMS AMOUNTED TO SEK
-2,049,565
(-771,779) IN Q2
    * HALF YEAR GROUP'S LOSS AFTER FINANCIAL ITEMS AMOUNTED TO
SEK
3,224,953
    * HALF YEAR RESULT PER SHARE AMOUNTED TO SEK -0.21 (-0.13)

Source text for Eikon:  ID:nWkrHJqc7 
Further company coverage:  ODI.TE 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Odi Pharma AB (publ)

    See all news